Issuer positions
1
Reporting Owner Activity for Ramona Doyle
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
RECURSION PHARMACEUTICALS, INC.
Disclosed value
$1.28M
Recent activity
Available
- Owner positions from Forms 3/4/5
-
Reported position value
$1,280,811
Estimated from parsed Forms 3/4/5 when the filing discloses holding values.
Reported issuer count
1
Distinct issuers tied to this reporting owner in parsed SEC filings.
Largest reported position
RECURSION PHARMACEUTICALS, INC. (RXRX)
About $1.28M reported in parsed owner filings.
Latest owner filing
18 May 2022
Most recent owner-level filing date in the parsed SEC record.
How to read Forms 3/4/5 positions
- Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough pricing and share data.
- Verify the source filing before treating any owner position as current.
- Location
- Salt Lake City, UT
- SEC signature
- /s/ Jonathan Golightly, attorney-in-fact
- Source evidence
- Open source filing history
SEC ownership signals
1 fact
Identity
1 fact
SEC filing record
1 fact
SEC evidence
1 fact
Follow Filing Activity
Follow Ramona Doyle and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Ramona Doyle
RXRX
Forms 3/4/5
RECURSION PHARMACEUTICALS, INC.
- Relationship
- Chief Medical Officer
- Holdings value
- $1,280,811
- Past year net change
- Change %
- Report period
- 16 May 2022
Insider Transactions Reported by Ramona Doyle:
| Sym | Company | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.